Caliper Life Sciences' Fourth Quarter and Fiscal Year 2010 Financial Results Conference Call Notice
HOPKINTON, Mass., February 11, 2011 -- Caliper Life Sciences, Inc. (NASDAQ: CALP) will
conduct a conference call discussing the company's fourth quarter and fiscal year 2010 financial
results at 5:00 pm Eastern (2:00 pm Pacific) on Wednesday, February 23, 2011. Kevin
Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer,
will host the call. Management will discuss operational and financial results and the company's
outlook for the future.
A news release discussing Caliper's fourth quarter and fiscal year 2010 financial results will be
issued on Wednesday, February 23, following the close of market.
Participants, please call 888.713.4215 five to ten minutes prior to the call and use the participant
passcode of 76273346. International callers can access the call by dialing 617.213.4867 and
entering the same passcode. You may also pre-register for the call at
https://www.theconferencingservice.com/prereg/key.process?key=P787YXXD6.
A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website
at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of
the call will remain available until Caliper's earnings call for the first quarter of 2011.
Telephone replays of the conference call will be available approximately two hours after the
completion of the call. To access a telephone playback of the proceedings from February 23
through March 2, dial 888-286-8010 and use the participant passcode of 91056059. International
callers can access the playback by dialing 617-801-6888 and using the same participant
passcode.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in
the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more
quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap
between in vitro assays and in vivo results, enabling the translation of those results into cures for
human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab
automation & liquid handling, optical imaging technologies, and discovery & development
outsourcing solutions. For more information please visit www.caliperLS.com.
Contact:
Peter McAree
SVP and Chief Financial Officer
774.278.2215
